83 related articles for article (PubMed ID: 975103)
21. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
Kahan BD; Tanaka T; Pellis NR
J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
[TBL] [Abstract][Full Text] [Related]
22. Alien-driven diversity and alien-selected escape: a rationale for allogeneic cancer immunotherapy.
Sondel PM; Hank JA
Transplant Proc; 1981 Dec; 13(4):1915-21. PubMed ID: 7036482
[TBL] [Abstract][Full Text] [Related]
23. Establishment of three monoclonal antibodies specific for prespermatogonia and intratubular malignant germ cells in humans.
Hiraoka N; Yamada T; Abe H; Hata J
Lab Invest; 1997 Mar; 76(3):427-38. PubMed ID: 9121125
[TBL] [Abstract][Full Text] [Related]
24. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
25. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
Gorelik E; Peppoloni S; Overton R; Herberman RB
Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
[TBL] [Abstract][Full Text] [Related]
26. Partial purification of C-C36 tumor rejection antigen molecules commonly expressed on syngeneic murine colon tumors, C-C36 and C-C26.
Sato N; Sato T; Takahashi S; Fujimoto N; Koshiba H; Ishii Y; Kikuchi K
Jpn J Cancer Res; 1986 May; 77(5):473-9. PubMed ID: 3089978
[TBL] [Abstract][Full Text] [Related]
27. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
Tanida S; Uchida H; Taniguchi K; Nomoto K
Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
[TBL] [Abstract][Full Text] [Related]
28. A set of stage-dependent embryonic antigens expressed in cell cultures of BALB/c mouse embryos and in transformed cell lines.
Gerhards RE; Mehnert FE
J Cell Biochem; 1986; 31(1):27-39. PubMed ID: 3013908
[TBL] [Abstract][Full Text] [Related]
29. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].
Prikler L; Scandella E; Men Y; Engeler DS; Diener PA; Gillessen S; Ludewig B; Schmid HP
Aktuelle Urol; 2004 Aug; 35(4):326-30. PubMed ID: 15459874
[TBL] [Abstract][Full Text] [Related]
30. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
31. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
32. Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A
Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759
[TBL] [Abstract][Full Text] [Related]
33. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
34. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
35. [Interspecific embryonic antigens in the blood serum of cancer patients].
Kalashnikov VV; Chekhonin VP; Tatarinov IuS
Vopr Onkol; 1983; 29(4):24-9. PubMed ID: 6858045
[TBL] [Abstract][Full Text] [Related]
36. Differentiation antigens defined by mouse monoclonal antibodies against human germ cell tumors.
Fujimoto J; Hata J; Ishii E; Tanaka S; Kannagi R; Ueyama Y; Tamaoki N
Lab Invest; 1987 Oct; 57(4):350-8. PubMed ID: 2823004
[TBL] [Abstract][Full Text] [Related]
37. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
Tsujino M
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
[TBL] [Abstract][Full Text] [Related]
38. [Tumor immunology (author's transl)].
Barandun S; Morell A
Pathol Microbiol (Basel); 1975; 42(4):302-11. PubMed ID: 778765
[TBL] [Abstract][Full Text] [Related]
39. Effects of antitumour immunity on pregnancy in the mouse.
Parmiani G; Della Porta G
Nat New Biol; 1973 Jan; 241(105):26-8. PubMed ID: 4512327
[No Abstract] [Full Text] [Related]
40. [Limits and possibilities of neoplasm immunotherapy].
Kurth R
Naturwissenschaften; 1978 Apr; 65(4):180-7. PubMed ID: 78457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
